Why Technology Is Significant In Getting Virtual Clinical Trials Running
It is time to make bold changes in clinical trials. The COVID-19 pandemic has proved that it is the universal disruptor of the traditional clinical trial model that is followed globally. The pharmaceutical industry has been forced to apply new strategies of working to ensure the safety of patients. The restriction in physical interactions has increased the implementation of advanced techniques to new and current trial designs. Virtual clinical trial models can be a successful alternative to traditional clinical trials.
The traditional trial processes are managed in a top-down method and a closely monitored environment, making them expensive and inefficient. The procedure is also dependent on the manual collection of data from sites that utilize a combination of paper-based and electronic techniques.
When the patients have to physically go to the sites, it can make to trials inconvenient and inaccessible for the one who needs it the most. On the other hand, with the help of virtual trials, the patient s can participate remotely. It is designed so that the data can directly flow from the patient’s home to the electronic records or electronic data capture systems efficiently.
Moving forward with the virtual clinical trials requires the utilization and adoption of digital technologies like digital data collection tools like wearable devices, telehealth platforms, and electronic informed consent. Clinical trials are also necessary to explore more advanced technologies like automated data collection, artificial intelligence, collaboration tools, and machine learning. Despite innovative technologies, all of them are a single piece of the puzzle necessary to implement in the clinical trial models successfully. It is also essential for the sponsors to accomplish sustainable transformation in the bold patient-based move to virtual clinical trials.
How AI And CPV Can Help In Pharmaceutical Manufacturing:
The process of pharmaceutical development of novel drugs can be complicated and tedious. The information shared among the multidisciplinary team is essential for decreasing expenses and accelerating the path of bringing the drug to market. To accomplish transparency and actionability of data, the pharmaceutical organizations are developing their manufacturing procedure by digitalizing the data from every equipment.
Technologies like the internet of things (IoT) and clod permit process experts and data scientists to work collaboratively to increase the process understanding and design analytical tools for maintaining the processes under a defined state of control. When this process is followed continuously, it is defined as continuous process verification (CPV). Today, it has become an essential process for the pharmaceutical organization to meet consumers’ demands, especially during a global pandemic.
Most importantly, this era’s diseases have changed because of the increase in the human population, higher expectancy of life, and the new pandemic viruses are successfully collapsing the healthcare system.
Pharmaceutical organizations have to develop several strategies to produce a wide variety of innovative therapy medicinal products (ATMP) and biological products. The works consist of recombinant proteins, CAR-T cells and oncolytic viruses, monoclonal antibodies, and recombinant proteins to deliver new medical requirements in the society. Read More….
